ScPharmaceuticals Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Name	Title	Email/Phone
1 John Tucker	CEO	Reveal Email/Phone
2 John Tucker	CEO & President	Reveal Email/Phone
3 Matthew Goodwin	VP Medical Affairs	Reveal Email/Phone
4 John Mohr	SVP, Clinical Development and Medical Affairs	Reveal Email/Phone
5 Michelle Whipple	Head Quality Assurance	Reveal Email/Phone
6 Carolyn Scimemi	VP, Legal Affairs & Compliance	Reveal Email/Phone
7 Eric Kendig	VP, Head Regulatory Affairs	Reveal Email/Phone
8 Lucy Johnston	VP Program Management and Regulatory Affairs	Reveal Email/Phone
9 Clayton Hines	Controller	Reveal Email/Phone
10 Steven Parsons	VP, Head Commercial: Marketing, Market Access, Sales & Operations	Reveal Email/Phone

keywords:N/A

N/A

Total Funding

156

Number of Employees

$7.5M

Revenue (est)

21%

Employee Growth %

$111.9M

Valuation

N/A

Accelerator

Scpharmaceuticals Inc (SCPH) stock is down -13.28% over the last 12 months, and the average rating from Wall Street analysts is a Buy.

scPharmaceuticals Inc. Announces Resubmission of FUROSCIX® New Drug Application. Anticipates Q4 2022 commercial launch, if approved. April 11,...

scPharmaceuticals Inc. (NASDAQ:SCPH Get Rating) major shareholder 5Am Partners Iv, Llc sold 270,000 shares of the business's stock in a...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Usher Transport	$56.3M	156	7%	N/A
#2 Stichting Sint ...	$30.9M	156	12%	N/A
#3 Every Angle US	$24.9M	156	N/A	N/A
#4 Lasting Softwar...	$24.9M	156	N/A	N/A
#5 PINTEC	$24.9M	156	N/A	N/A